Mines D'Or Orbec Inc. (BLUE)
Jun 2, 2025 - BLUE was delisted (reason: acquired by Carlyle and SK Capital)
4.970
0.00 (0.00%)
Inactive · Last trade price on May 30, 2025
bluebird bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
248
Market Cap
3.59M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBLUE News
- 5 weeks ago - bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots - Business Wire
- 4 months ago - bluebird bio Strengthens Leadership Team With New Appointments - Business Wire
- 5 months ago - bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital - Business Wire
- 5 months ago - Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer - Business Wire
- 5 months ago - bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital - Business Wire
- 5 months ago - Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions - Business Wire
- 6 months ago - Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital - Reuters
- 6 months ago - Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement - Business Wire